A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 491,255 shares of AMGN stock, worth $155 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
491,255
Previous 479,325 2.49%
Holding current value
$155 Million
Previous $150 Million 5.69%
% of portfolio
0.22%
Previous 0.22%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$309.38 - $337.38 $3.69 Million - $4.02 Million
11,930 Added 2.49%
491,255 $158 Million
Q2 2024

Jul 19, 2024

BUY
$262.75 - $319.31 $3.05 Million - $3.7 Million
11,589 Added 2.48%
479,325 $150 Million
Q1 2024

Apr 22, 2024

BUY
$268.87 - $324.56 $3.72 Million - $4.49 Million
13,820 Added 3.04%
467,736 $133 Million
Q4 2023

Jan 16, 2024

BUY
$255.7 - $288.46 $2.12 Million - $2.4 Million
8,305 Added 1.86%
453,916 $131 Million
Q3 2023

Oct 24, 2023

BUY
$218.65 - $271.46 $657,917 - $816,823
3,009 Added 0.68%
445,611 $120 Million
Q2 2023

Jul 25, 2023

BUY
$214.27 - $253.37 $1.57 Million - $1.85 Million
7,317 Added 1.68%
442,602 $98.3 Million
Q1 2023

Apr 14, 2023

BUY
$225.79 - $275.2 $1.91 Million - $2.33 Million
8,465 Added 1.98%
435,285 $105 Million
Q4 2022

Feb 08, 2023

SELL
$229.03 - $291.01 $6.2 Million - $7.88 Million
-27,082 Reduced 5.97%
426,820 $112 Million
Q3 2022

Oct 25, 2022

SELL
$224.46 - $253.15 $5.36 Million - $6.04 Million
-23,859 Reduced 4.99%
453,902 $102 Million
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $1.25 Million - $1.39 Million
-5,427 Reduced 1.12%
477,761 $116 Million
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $5.22 Million - $5.77 Million
23,797 Added 5.18%
483,188 $117 Million
Q4 2021

Feb 08, 2022

BUY
$198.88 - $227.6 $2.98 Million - $3.41 Million
14,968 Added 3.37%
459,391 $103 Million
Q3 2021

Nov 02, 2021

BUY
$212.27 - $248.7 $2.91 Million - $3.41 Million
13,692 Added 3.18%
444,423 $94.5 Million
Q2 2021

Aug 11, 2021

SELL
$233.58 - $259.14 $88.6 Million - $98.3 Million
-379,393 Reduced 46.83%
430,731 $105 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $15.4 Million - $17.9 Million
69,402 Added 9.37%
810,124 $202 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $652,602 - $777,132
3,016 Added 0.41%
740,722 $170 Million
Q3 2020

Nov 04, 2020

BUY
$234.65 - $260.95 $21.6 Million - $24.1 Million
92,261 Added 14.29%
737,706 $188 Million
Q2 2020

Jul 17, 2020

BUY
$197.81 - $242.74 $76.2 Million - $93.5 Million
384,997 Added 147.82%
645,445 $152 Million
Q1 2020

Apr 21, 2020

BUY
$182.24 - $241.7 $3.38 Million - $4.48 Million
18,545 Added 7.67%
260,448 $52.8 Million
Q4 2019

Feb 12, 2020

BUY
$189.21 - $243.2 $3.1 Million - $3.99 Million
16,394 Added 7.27%
241,903 $58.3 Million
Q3 2019

Nov 07, 2019

SELL
$174.11 - $208.62 $1.74 Million - $2.08 Million
-9,968 Reduced 4.23%
225,509 $43.6 Million
Q2 2019

Aug 06, 2019

SELL
$166.7 - $195.41 $359,238 - $421,108
-2,155 Reduced 0.91%
235,477 $43.4 Million
Q1 2019

May 06, 2019

SELL
$180.87 - $203.88 $333,162 - $375,546
-1,842 Reduced 0.77%
237,632 $45.1 Million
Q4 2018

Feb 11, 2019

BUY
$178.4 - $208.25 $1.18 Million - $1.38 Million
6,633 Added 2.85%
239,474 $46.6 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $2.64 Million - $2.98 Million
14,251 Added 6.52%
232,841 $48.3 Million
Q2 2018

Jul 30, 2018

SELL
$166.05 - $186.51 $68,744 - $77,215
-414 Reduced 0.19%
218,590 $40.4 Million
Q1 2018

Apr 16, 2018

SELL
$169.43 - $198.0 $1.04 Million - $1.22 Million
-6,151 Reduced 2.73%
219,004 $37.3 Million
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $1.37 Million - $1.53 Million
8,135 Added 3.75%
225,155 $39.2 Million
Q3 2017

Oct 26, 2017

BUY
$167.29 - $191.0 $4.85 Million - $5.54 Million
28,988 Added 15.42%
217,020 $40.5 Million
Q2 2017

Aug 15, 2017

BUY
N/A
188,032
188,032 $32.4 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.